CureVac | LinkedIn
CureVac | LinkedIn
Mar 7, 2023
linkedin.com
CureVac N.V. Receives U.S. FDA Ind Clearance to Initiate Phase 1 Clinical Trial for Novel Mrna-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
CureVac N.V. Receives U.S. FDA Ind Clearance to Initiate Phase 1 Clinical Trial for Novel Mrna-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
Apr 7, 2025
marketscreener.com
Gold prices, BioNTech to acquire CureVac, Tapestry upgrade
1:03
Gold prices, BioNTech to acquire CureVac, Tapestry upgrade
10 months ago
Yahoo
CureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy
CureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy
Jun 18, 2021
inquirer.net
CureVac fails in pivotal Covid-19 vaccine trial with 47% efficacy
CureVac fails in pivotal Covid-19 vaccine trial with 47% efficacy
Jun 16, 2021
straitstimes.com
What to Expect From Novavax and CureVac Covid-19 Vaccines
8:02
What to Expect From Novavax and CureVac Covid-19 Vaccines
Jun 16, 2021
Bloomberg.comNaomi Kresge,Tim Loh
Did Germany's CureVac COVID vaccine ultimately fail?
4:09
Did Germany's CureVac COVID vaccine ultimately fail?
Jun 17, 2021
DW.COMAshutosh Pandey,Alexander Freund
4:14
Did Germany's CureVac COVID vaccine ultimately fail?
Jun 17, 2021
DW.COM
GSK, CureVac to make COVID-19 vaccines aimed at new variants
Feb 3, 2021
wthr.com
Impfstoff von Curevac hat entscheidenden Vorteil gegenüber Biontech
Feb 28, 2025
bw24.de
1:17
CureVac has announced an alliance with Bayer, as the German biotech firm starts a late-stage clinical trial of its COVID-19 vaccine candidate https://reut.rs/3pWCN1X | Reuters
4.4K viewsJan 7, 2021
FacebookReuters
1:16
CureVac strikes COVID vaccine alliance with Bayer
71.1K viewsJan 7, 2021
YahooReuters Videos
Curevac-Studie mit enttäuschendem Ergebnis: Corona-Impfstoff aus Deutschland kaum wirksam
Jun 17, 2021
hna.de
2:10
CureVac begins phase 3 study of possible vaccine
Dec 14, 2020
wthr.com
CureVac to Release Results of Covid Vaccine Trials
Apr 15, 2021
Bloomberg.com
CureVac Covid vaccine shows immune response in early trial, on track for advanced trial
Nov 2, 2020
theprint.in
BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals
10 months ago
marketscreener.com
COVID ваксината на CureVac е показала ниска ефективност — OFFNews
Jun 17, 2021
offnews.bg
CureVac Shares Plunge Premarket on Disappointing Covid-19 Vaccine Trial
1 year ago
wsj.com
CureVac Covid-19 Vaccine Is 48% Effective in Pivotal Study
Jun 30, 2021
wsj.comLaura Cooper
CureVac Value Halves in Reminder of Vaccine Research Risks
1 year ago
wsj.com
GSK buys full rights to make COVID, influenza vaccines from CureVac
Jul 2, 2024
marketscreener.com
0:39
We’re building on our relationship with Germany-based CureVac, with a new collaboration aiming to develop next-generation mRNA vaccines for #COVID19, beginning immediately. We will also support the manufacture of 100 million doses of CureVac’s first-generation COVID-19 vaccine candidate in 2021. https://gsk.to/3jah3xH Watch this video to learn more about mRNA vaccines. | GSK
5.1K viewsFeb 3, 2021
FacebookGSK
6:00
CureVac Shelves Covid-19 Vaccine, Focuses on Next-Generation Shot
Oct 12, 2021
WSJDenise Roland
8:27
CureVac Joins GlaxoSmithKline to Make Next-Gen Covid Shot
Feb 3, 2021
YahooBloomberg Technology
Elon Musk: Tesla's RNA vaccine printer for CureVac is going to be 'important product for the world'
Nov 10, 2020
electrek.co
2:44
CureVac is focusing on mRNA cancer vaccines, CFO says
Sep 20, 2022
CNBC
CureVac ima učinkovitost samo 47 posto, što će se dogoditi sa stotinama milijuna doza za EU?
Jun 17, 2021
slobodnadalmacija.hr
4:28
CureVac working on a second generation vaccine to combat Covid variants, CEO says
Feb 12, 2021
CNBC
5:29
There needs to be an international endeavor to distribute vaccines across borders, CureVac CEO says
Apr 8, 2021
CNBCHolly Ellyatt
See more